Orteronel

Generic Name: Orteronel

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₁₇N_₃O_₂

CAS Number: 566939-85-3

Unique Ingredient Identifier: UE5K2FNS92

Background: Orteronel has been investigated for the treatment of Prostate Cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone

Elevated circulating tumor cell (CTC) count at baseline in metastatic hormone-sensitive prostate cancer (mHSPC) is associated with worse overall survival, progression-free survival, and treatment response, validating CTC count as a prognostic biomarker that improves existing prognostic factors and estimates divergent survival outcomes regardless of subsequent therapies.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy